Daniel Dolan SEC EDGAR Filings (CIK 0001826818)

SEC EDGAR filings, ownership reports, and insider transactions for Daniel Dolan.

Business address
C/O Nabriva Therapeutics Plc, 1000 Continental Drive, Suite 600, King Of Prussia, PA, 19406
Get insider transactions for this reporting owner
Daniel Dolan has filed 6 SEC EDGAR filings since 06 Oct 2020

Latest Filings

Recent SEC filings for Daniel Dolan including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 15 Aug 2022 11 Aug 2022 001-37558
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 01 Feb 2022 28 Jan 2022 001-37558
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Apr 2021 31 Mar 2021 001-37558
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 16 Mar 2021 12 Mar 2021 001-37558
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Nov 2020 09 Nov 2020 001-35726
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 06 Oct 2020 24 Sep 2020 001-35726

About this filer

Daniel Dolan files with the SEC under CIK 0001826818. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages